177 related articles for article (PubMed ID: 34209694)
1. SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Offersgaard A; Duarte Hernandez CR; Pihl AF; Costa R; Venkatesan NP; Lin X; Van Pham L; Feng S; Fahnøe U; Scheel TKH; Ramirez S; Reichl U; Bukh J; Genzel Y; Gottwein JM
Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34209694
[TBL] [Abstract][Full Text] [Related]
2. Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle.
Choi HY; Choi JC; Kang YL; Ahn SH; Lee SW; Park SY; Song CS; Choi IS; Lee JB
BMC Vet Res; 2023 Aug; 19(1):105. PubMed ID: 37528389
[TBL] [Abstract][Full Text] [Related]
3. High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.
Offersgaard A; Duarte Hernandez CR; Pihl AF; Venkatesan NP; Krarup H; Lin X; Reichl U; Bukh J; Genzel Y; Gottwein JM
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214707
[TBL] [Abstract][Full Text] [Related]
4. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
5. Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures.
Fulber JPC; Farnós O; Kiesslich S; Yang Z; Dash S; Susta L; Wootton SK; Kamen AA
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835266
[TBL] [Abstract][Full Text] [Related]
6. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density.
Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175
[TBL] [Abstract][Full Text] [Related]
7. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
8. Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor.
Nie J; Sun Y; Peng F; Li X; Yang Y; Liu X; Li Y; Liu C; Bai Z
J Pharm Sci; 2020 Feb; 109(2):959-965. PubMed ID: 31604085
[TBL] [Abstract][Full Text] [Related]
9. Assessment of packed bed bioreactor systems in the production of viral vaccines.
Rajendran R; Lingala R; Vuppu SK; Bandi BO; Manickam E; Macherla SR; Dubois S; Havelange N; Maithal K
AMB Express; 2014; 4():25. PubMed ID: 24949260
[TBL] [Abstract][Full Text] [Related]
10. High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors.
Todesco HM; Gafuik C; John CM; Roberts EL; Borys BS; Pawluk A; Kallos MS; Potts KG; Mahoney DJ
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101189. PubMed ID: 38327804
[TBL] [Abstract][Full Text] [Related]
11. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
[TBL] [Abstract][Full Text] [Related]
12. Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
Schirtzinger EE; Kim Y; Davis AS
J Virol Methods; 2022 Jan; 299():114317. PubMed ID: 34634321
[TBL] [Abstract][Full Text] [Related]
13. Process optimization for the rapid production of Enterovirus 71.
Wu XX; Chen KD; Chen DZ; Xiao LL; Huang KZ; Zhang YJ; Li LJ
Cytotechnology; 2019 Dec; 71(6):1053-1061. PubMed ID: 31559514
[TBL] [Abstract][Full Text] [Related]
14. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
15. Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor.
Ton C; Stabile V; Carey E; Maraikar A; Whitmer T; Marrone S; Afanador NL; Zabrodin I; Manomohan G; Whiteman M; Hofmann C
Biotechnol Rep (Amst); 2023 Mar; 37():e00782. PubMed ID: 36687766
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
[TBL] [Abstract][Full Text] [Related]
17. High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes.
Sedighikamal H; Sattarzadeh A; Karimi Mostofi R; Dinarvand B; Nazarpour M
ACS Omega; 2023 Oct; 8(40):36720-36728. PubMed ID: 37841195
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
[TBL] [Abstract][Full Text] [Related]
19. Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccine.
Rosen O; Jayson A; Goldvaser M; Dor E; Monash A; Levin L; Cherry L; Lupu E; Natan N; Girshengorn M; Epstein E
Biotechnol Bioeng; 2022 Jul; 119(7):1839-1848. PubMed ID: 35319097
[TBL] [Abstract][Full Text] [Related]
20. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
